Application 212022
- Type
- ANDA
- Sponsor
- JIANGSU HENGRUI MED
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | DAPTOMYCIN | DAPTOMYCIN | POWDER;INTRAVENOUS | 500MG/VIAL | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0143-9378 | Daptomycin | Daptomycin | Hikma Pharmaceuticals USA Inc. | ANDA | Current |
| 0143-9378 | Daptomycin | Daptomycin | Hikma Pharmaceuticals USA Inc. | ANDA | Current |
| 0143-9378 | Daptomycin | Daptomycin | Hikma Pharmaceuticals USA Inc. | ANDA | Current |
| 0143-9378 | Daptomycin | Daptomycin | Hikma Pharmaceuticals USA Inc. | ANDA | Current |
| 57884-3151 | Daptomycin | Daptomycin | Jiangsu Hengrui Medicine Co., Ltd. | ANDA | Current |